MARATTO

article · Schizophrenia Research

Dopamine receptor D2 (DRD2) TaqIA gene polymorphism and acute risperidone-induced changes in body weight, plasma glucose and lipid profile

20251 citation

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Diet and metabolism studies
  • Schizophrenia research and treatment
  • Pharmacology and Obesity Treatment

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.schres.2025.03.005

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.